Carpenter C B, Milford E L, Kirkman R L, Strom T B, Lazarus J M, Tilney N L
Transplant Proc. 1985 Aug;17(4 Suppl 1):261-5.
Forty-eight patients with stable renal function after allotransplantation have been converted from CsA/prednisone to azathioprine/prednisone to assess the short- and long-term effects upon renal function. Virtually all patients show an initial improvement in serum creatinine levels. Three patients developed chronic renal failure after 12 to 21 months, and three died of pneumonia 7, 12, and 19 months later. The mean serum creatinine level at latest follow-up (seven to 36 months) was 2.5 +/- 1.5 mg/dL for all 48 patients. Of interest, a control group of 21 patients not converted to azathioprine had serum creatinine levels of 2.5 +/- 0.8 mg/dL, over a follow-up period of five to 25 months. It is not immediately apparent that either group will have a superior overall outcome, although patients on azathioprine seem to have more of a risk for graft loss. More data are needed with various dosage schedules, and with randomized controls.
48例同种异体移植后肾功能稳定的患者已从环孢素/泼尼松转换为硫唑嘌呤/泼尼松,以评估对肾功能的短期和长期影响。几乎所有患者的血清肌酐水平都有初步改善。3例患者在12至21个月后出现慢性肾衰竭,3例分别在7、12和19个月后死于肺炎。48例患者在最近一次随访(7至36个月)时的平均血清肌酐水平为2.5±1.5mg/dL。有趣的是,21例未转换为硫唑嘌呤的对照组患者在5至25个月的随访期内血清肌酐水平为2.5±0.8mg/dL。虽然服用硫唑嘌呤的患者似乎有更高的移植丢失风险,但目前尚不清楚哪一组的总体预后更好。需要更多关于不同剂量方案以及随机对照的数据。